...engagements MedMonitor An up-to-date timeline of FDA approvals that could impact workers' comp View All MedMonitor Information Social Hub Check out our latest posts and activity View All Social Media...
...nausea Imuldosa should not be used in patients with active infections, tuberculosis, malignancies, hypersensitivity, and noninfectious pneumonia. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp,...
...This comes after reports of serious heart problems and deaths from much higher than recommended doses of loperamide. These adverse events are due to loperamide's increased use as a drug...
...drugs that do not provide hallucinogenic effects – and possibly minimize more addictive elements. The new study tested if the psychedelic compound DOI (2,5-dimethoxy-4-iodoamphetamine) could reduce anxiety in mice by...
The California Division of Workers’ Compensation (DWC) adopted long-awaited Pharmaceutical Fee Schedule rules, introducing major changes to pharmaceutical billing and reimbursement. While there are many updates to the new rules,...
...in the workers’ compensation industry have become experts in managing this particular area of concern, these latest numbers remind us that opioid management continues to be more important than ever....
The California Division of Workers' Compensation (DWC) released its annual report on the Independent Medical Review (IMR) program, managed by Maximus Federal Services. IMRs resolve disputes over treatment denials or...
The National Council on Compensation Insurance (NCCI) released its latest Labor Market Insights report, offering a snapshot of current employment trends and their potential impact on workers’ compensation. By highlighting...
Many clinical trials are underway for drugs to combat COVID-19, but the FDA gave special notice to two drugs. Gilead Sciences initiated two Phase 3 studies of the investigational antiviral...
...Alzheimer’s could interfere with medication adherence, particularly if patients also have a comorbidity. For ongoing coverage of the latest drug approvals and alerts impacting workers’ comp, visit Med Monitor online....
Healthesystems’ VP of Clinical Services, Silvia Sacalis, BS, PharmD, was featured in the International Association of Industrial Accident Boards and Commissions’ (IAIABC) Perspectives publication. Dr. Sacalis penned an article on...
Healthesystems' Advocacy and Compliance team recently attended the NCCI Annual Insights Symposium in Orlando, Florida. This event brings together executive leaders and actuaries from the workers' compensation industry to hear...
...drug would be the first oral antiviral medication for COVID-19. For all of the latest updates on FDA drug approvals impacting workers’ comp, check out our interactive web tool, MedMonitor....
...populations include healthcare workers. Recently, ViiV Healthcare, a GlaxoSmithKline company, communicated to the FDA that several HIV medications they manufacture will be discontinued by the end of 2023. While many...
...for Priority Review the New Drug Application (NDA) for MDMA capsules in combination with psychological intervention for the treatment of PTSD. While this has been long coming, with the FDA...
